KATALYST & Co. Healthcare Transformation Platform Launches with $10 Million in Funding
Kat Marie Alvarez, RN, MBA, Founder & Chief Executive Officer of KATALYST & Co., announces a healthcare transformation and investment...
Year: 2025
Genesis Medical Detox Expands Into Kentucky, Bringing Compassionate, Medically Supervised Detox Services to Western Kentucky
MAYFIELD, KY / ACCESS Newswire / October 29, 2025 / Genesis Medical Detox is proud to announce the opening of...
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"),...
Dr. Mansher Singh Recognized Among America’s Top Facelift Surgeons and Earns Triple Board Certification
Setting a New Standard for Facial Rejuvenation and Aesthetic Expertise NEW YORK CITY, NY / ACCESS Newswire / October 29,...
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000...
Global Initiative To Demonstrate Operational Excellence in Nigeria for Metastatic Colorectal Cancer Patients
NORTHAMPTON, MA / ACCESS Newswire / October 29, 2025 / Bristol-Myers Squibb Company - Recently, the Innovative Cancer Medicines (ICM)...
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company...
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations
LITS Board of Directors Reaffirms Commitment to Driving Long-Term Stockholder ValueSAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lite Strategy,...
National Survey Reveals Persistent Gaps in Pediatric Care Experiences Among U.S. Families
Zarminali Pediatrics releases data emphasizing the need for more connected, coordinated careCHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics,...
Vivian Health Partners with Hallmark to Power Faster, Smarter Hiring
New integration connects Vivian, the largest healthcare talent marketplace, with Hallmark’s Workforce Intelligence and Enablement Platform—streamlining travel nurse and allied...
Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated...
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwideStrategy centers...
Aeroflow Health and UnitedHealthcare Partner to Deliver Virtual Nutrition Services Nationwide
The partnership enables UnitedHealthcare to integrate telehealth nutrition services across Commercial and Medicare plans to enhance patient wellnessASHEVILLE, N.C., Oct....
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to...
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
PolarityBio Announces Acceptance of Category III CPT® Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT® Editorial Panel
Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin ConstructSALT LAKE CITY, Oct. 29, 2025...
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early...
PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
PETACH TIKVA, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company...
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics
Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to...